Timothy Miller
Fortune : 406 169 $ au 31/05/2026
Fortune : 406 169 $ au 31/05/2026
Timothy J.
Miller is President, Chief Executive Officer & Director at Forge Biologics Holdings LLC.
Dr. Miller is Independent Director at Research Alliance Corp.
III starting in 2026.
Formerly, Dr. Miller was President, Chief Executive Officer & Director at Abeona Therapeutics, Inc. from 2015 to 2018.
Dr. Miller was President & Chief Executive Officer at Abeona Therapeutics LLC from 2013 to 2015.
Dr. Miller was President & Chief Executive Officer at Red5 Pharmaceuticals LLC from 2013 to 2015.
Dr. Miller was Senior Director-Product Development at SironRX Therapeutics, Inc. from 2010 to 2013.
Dr. Miller was Vice President-Business Development at BioEnterprise Corp.
Education includes a doctorate from Case Western Reserve University and undergraduate and graduate degrees from John Carroll University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
2,96 % | 20/05/2026 | 39 130 ( 2,96 % ) | 406 169 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Forge Biologics Holdings LLC
Forge Biologics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Directeur Général | 02/04/2018 |
Abeona Therapeutics LLC
Abeona Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops therapies for patients with lysosomal storage diseases | Directeur Général | 01/01/2015 |
Red5 Pharmaceuticals LLC
Red5 Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and wholesales therapeutic pharmaceuticals against cancer | Directeur Général | 01/01/2015 |
BioEnterprise Corp.
BioEnterprise Corp. Miscellaneous Commercial ServicesCommercial Services Initiates for start up funding, and networking information, recruitment and emerging support firms | Corporate Officer/Principal | 01/01/2015 |
SironRX Therapeutics, Inc.
SironRX Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides regenerative therapies for cardiovascular disease | Corporate Officer/Principal | 01/01/2013 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Abeona Therapeutics, Inc.
Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Abeona Therapeutics LLC
Abeona Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops therapies for patients with lysosomal storage diseases | Health Technology |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
John Carroll University
John Carroll University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioEnterprise Corp.
BioEnterprise Corp. Miscellaneous Commercial ServicesCommercial Services Initiates for start up funding, and networking information, recruitment and emerging support firms | Commercial Services |
SironRX Therapeutics, Inc.
SironRX Therapeutics, Inc. Hospital/Nursing ManagementHealth Services Provides regenerative therapies for cardiovascular disease | Health Services |
Red5 Pharmaceuticals LLC
Red5 Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and wholesales therapeutic pharmaceuticals against cancer | Health Technology |
Forge Biologics Holdings LLC
Forge Biologics Holdings LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national